BELLUS Health Inc. Gains 16.53%

Tue, Sep 14, 2021 at 05:30 PM
BELLUS Health Inc. Gains 16.53%

BELLUS Health Inc. (BLU:NASDAQ) soared at $5.57, representing a gain of 16.5%. On Mon, Sep 13, 2021, BLU:NASDAQ touched a New 2-Week High of $4.78. The stock appeared on our News Catalysts scanner on Mon, Sep 13, 2021 at 09:33 AM in the 'BIOTECH' category. From Mon, Aug 30, 2021, the stock recorded 66.67% Up Days and 50.00% Green Days

About BELLUS Health Inc. (BLU:NASDAQ)

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, development of drug candidates for health solutions.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.